Rivaroxaban 10 MG Oral Tablet

DRUG3 trials

Sponsors

Onze Lieve Vrouw Hospital, Insel Gruppe AG, University Hospital Bern, Thomas Jefferson University

Conditions

Atrial FibrillationBreast Milk CollectionBreastfeedingLiver CirrhosisPostpartumRivaroxabanVTE (Venous Thromboembolism)VTE Prophylaxis

Phase 1

Direct Oral Anticoagulants (Rivaroxaban and Apixaban) in Patients With Liver Cirrhosis

RecruitingNCT04874428

Insel Gruppe AG, University Hospital BernLiver Cirrhosis

Start: 2021-05-19End: 2026-06-01Target: 24Updated: 2026-02-25

Excretion of Rivaroxaban in Human Breast Milk

RecruitingNCT06831474

Thomas Jefferson UniversityBreastfeeding, Breast Milk Collection, Postpartum +3

Start: 2025-07-31End: 2026-07-31Target: 10Updated: 2025-07-17

Phase 4

Oral Anticoagulation in Hemodialysis

CompletedNCT03799822

Onze Lieve Vrouw HospitalAtrial Fibrillation

Start: 2017-05-01End: 2020-10-01Updated: 2020-11-03

Related Papers

Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients with Atrial Fibrillation: A Multicenter Randomized Controlled Trial

Journal of the American Society of Nephrology2021-03-22170 citations